UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005175
Receipt number R000006143
Scientific Title Efficacy of BBG-01 (Bifidobacterium breve) on pre and postoperative infectious complications of infants in Juntendo University Hospital
Date of disclosure of the study information 2011/03/03
Last modified on 2024/03/11 13:35:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of BBG-01 (Bifidobacterium breve) on pre and postoperative infectious complications of infants in Juntendo University Hospital

Acronym

Efficacy of BBG-01 administration for infants

Scientific Title

Efficacy of BBG-01 (Bifidobacterium breve) on pre and postoperative infectious complications of infants in Juntendo University Hospital

Scientific Title:Acronym

Efficacy of BBG-01 administration for infants

Region

Japan


Condition

Condition

Pediatric inpatients scheduled for gastrointestinal and urogenital surgery

Classification by specialty

Surgery in general Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prevention of postoperative infectious complications

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

- Postoperative infectious complications
- Sepsis
- Intestinal microbiota
- Gastrointestinal function

Key secondary outcomes

- Length of hospital stay
- Blood biochemical indicators
- Intestinal environment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Bifidobacterium breve

Interventions/Control_2

Placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

15 years-old >

Gender

Male and Female

Key inclusion criteria

Children less than 15 years old who will undergo operations at the Department of Pediatric General and Urogenital Surgery of Juntendo University Hospital

Key exclusion criteria

- A subject who cannot ingest the test diet due to intestinal dysfunction.
- A subject whose operation is cancelled.
- A subject who is not suitable for the trial defined by the attending researcher.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Atsuyuki
Middle name
Last name Yamataka

Organization

Juntendo University School of Medicine

Division name

Department of Pediatric Surgery

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan

TEL

03-3813-3111

Email

yama@juntendo.ac.jp


Public contact

Name of contact person

1st name Tadaharu
Middle name
Last name Okazaki

Organization

Juntendo University School of Medicine

Division name

Department of Pediatric Surgery

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan

TEL

03-3813-3111

Homepage URL


Email

okazakit@juntendo.ac.jp


Sponsor or person

Institute

Division of Laboratory for Probiotic Research, Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Division of Laboratory for Probiotic Research, Juntendo University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Pediatric Surgery, Juntendo University School of Medicine

Name of secondary funder(s)

Yakult Honsha Co. Ltd.


IRB Contact (For public release)

Organization

Juntendo University Ethics Committee

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

+81-3-3813-3111

Email

gakujutu@juntendo.ac.j


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

gakujutu@juntendo.ac.jp


Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 03 Day


Related information

URL releasing protocol

https://www.juntendo.ac.jp/hospital/clinic/shonigeka/

Publication of results

Unpublished


Result

URL related to results and publications

https://journals.lww.com/jpgn/Fulltext/2016/07000/Intestinal_Microbiota_in_Pediatric_Surgical_Cases.

Number of participants that the trial has enrolled

30

Results

BBG-01 was well tolerated without adverse effects, and postoperative infectious complications were significantly decreased. Fecal analysis showed increased Bifidobacterium and decreased Enterobacteriaceae, Clostridium difficile, and Pseudomonas. Concentrations of fecal acetic acid were significantly increased, maintaining fecal pH at <7.0. The incidence of detecting bacteria in blood was significantly reduced.

Results date posted

2023 Year 03 Month 13 Day

Results Delayed


Results Delay Reason

Because of my lack of awareness of reporting obligation.

Date of the first journal publication of results

2016 Year 07 Month 01 Day

Baseline Characteristics

Children who undergo surgery

Participant flow

Patients who underwent surgery at Juntendo University Hospital were included in this study.

Adverse events

None

Outcome measures

Post-operative course and complications

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 04 Month 01 Day

Date of IRB

2011 Year 04 Month 20 Day

Anticipated trial start date

2009 Year 05 Month 01 Day

Last follow-up date

2012 Year 12 Month 31 Day

Date of closure to data entry

2012 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 03 Month 02 Day

Last modified on

2024 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006143